Our previous study demonstrated AKR1C3 could mediate chemoresistance via detoxification of ROS; additionally, emerging evidence suggested that AKR1C3 also enhanced radioresistance in esophageal squamous cancer cells (ESCC) [19, 57, 58]. The gene discussed is AKR1C3; the disease is esophageal squamous cell carcinoma.